S. Adeberg

E. B. Butler, S. Lo, B. Teh, 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma

A. Unterberg, D. Schrimpf, A. von Deimling, 2022, Acta Neuropathologica.

Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients

Nicolas G. R. Behl, M. Ladd, H. Schlemmer, 2020, NeuroImage: Clinical.

Re‐irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)

V. Budach, J. Debus, M. Krause, 2018, Cancer medicine.

Is a modification of the radiotherapeutic target volume necessary after resection of glioblastomas with opening of the ventricles?

A. Unterberg, J. Debus, S. Combs, 2016, Journal of Neuro-Oncology.

Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck

J. Debus, K. Herfarth, A. Mock, 2019, Front. Oncol..

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil

K. Herfarth, J. Debus, L. König, 2021, Strahlentherapie und Onkologie.

Treatment delay and tumor size in patients with oral cancer during the first year of the COVID‐19 pandemic

J. Hoffmann, S. Adeberg, O. Ristow, 2021, Head & neck.

Enrollment of Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer in Multi-institutional Trials of Proton Beam Radiation Therapy.

C. Simone, J. Rwigema, V. Verma, 2017, Clinical lung cancer.

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma

J. Debus, K. Herfarth, T. Haberer, 2016, Strahlentherapie und Onkologie.

Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer

K. Herfarth, J. Debus, P. Plinkert, 2019, Cancers.

Emerging Role of Carbon Ion Radiotherapy in Reirradiation of Recurrent Head and Neck Cancers: What Have We Achieved So Far?

H. Tsuji, S. Adeberg, M. Koto, 2022, Frontiers in Oncology.

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy

J. Debus, Michael Thomas, F. Herth, 2018, Cancer management and research.

Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy

A. Warth, J. Debus, Michael Thomas, 2017, Journal of Neuro-Oncology.

Nine‐year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small‐cell Lung Cancer

J. Debus, Michael Thomas, F. Herth, 2017, Clinical lung cancer.

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity

J. Debus, K. Freier, P. Plinkert, 2018, Cancers.

SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes.

J. Debus, F. Weykamp, L. König, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumor DNA‐methylome derived epigenetic fingerprint identifies HPV‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy

W. Weichert, V. Budach, A. Abdollahi, 2021, International journal of cancer.

Frequency of osteoradionecrosis of the lower jaw after radiotherapy of oral cancer patients correlated with dosimetric parameters and other risk factors

J. Debus, S. Adeberg, O. Ristow, 2022, Head & Face Medicine.

Definitive radiotherapy vs. postoperative radiotherapy for lower gingival carcinomas of the mandible

J. Debus, K. Freier, S. Akbaba, 2019, Strahlentherapie und Onkologie.

Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)

T. Welzel, J. Debus, P. Hoegen, 2022, Radiation oncology.

Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis

K. Herfarth, J. Debus, F. Sterzing, 2019, Cancer management and research.

S-phase–specific radiosensitization by gemcitabine for therapeutic carbon ion exposure in vitro

J. Debus, K. Weber, T. Haberer, 2016, Journal of radiation research.

Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.

A. von Deimling, J. Debus, C. Hartmann, 2012, International journal of radiation oncology, biology, physics.

Definitive Radiotherapy for Squamous Cell Carcinoma of The Oral Cavity: a Single-institution Experience

K. Zaoui, P. Plinkert, J. Debus, 2021, Radiology and oncology.

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?

J. Debus, A. Mohr, C. Koelsche, 2016, Stem cells international.

Large German Multicenter Experience on the Treatment Outcome of 207 Patients With Adenoid Cystic Carcinoma of the Major Salivary Glands

J. Debus, N. Rotter, P. Plinkert, 2020, Frontiers in Oncology.

Neck involvement and disease recurrence in adenoid cystic carcinoma of the minor salivary glands: the role of surgery in primary and progressive disease.

J. Hoffmann, K. Freier, C. Hofele, 2020, International journal of oral and maxillofacial surgery.

Treatment Outcome of 227 Patients with Sinonasal Adenoid Cystic Carcinoma (ACC) after Intensity Modulated Radiotherapy and Active Raster-Scanning Carbon Ion Boost: A 10-Year Single-Center Experience

J. Debus, K. Herfarth, A. Mock, 2019, Cancers.

Individualized 3D-Printed Tissue Retraction Devices for Head and Neck Radiotherapy

K. Herfarth, J. Debus, K. Zaoui, 2021, Frontiers in Oncology.

Malignant pleural mesothelioma - Pleural cavity irradiation after decortication with helical tomotherapy.

J. Debus, K. Herfarth, F. Sterzing, 2017, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands

K. Herfarth, J. Debus, K. Zaoui, 2021, Cancers.

Management of Clinically Lymph Node-Positive Malignant Pleural Mesothelioma.

C. Simone, J. Friedberg, V. Verma, 2020, Seminars in thoracic and cardiovascular surgery.

Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).

J. Debus, P. Huber, S. Combs, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy

K. Herfarth, J. Debus, F. Weykamp, 2022, Frontiers in Oncology.

Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial

K. Herfarth, T. Tessonnier, J. Debus, 2022, Radiation oncology.

Outcome after Radiotherapy for Vestibular Schwannomas (VS)—Differences in Tumor Control, Symptoms and Quality of Life after Radiotherapy with Photon versus Proton Therapy

K. Herfarth, P. Plinkert, J. Debus, 2022, Cancers.

Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff

K. Herfarth, J. Debus, S. Akbaba, 2019, Cancers.

The Phase I/II ACCEPT Trial: Concurrent Cetuximab and Intensity-Modulated Radiotherapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck: Cetuximab and IMRT/Carbon Ions for ACC.

J. Debus, K. Herfarth, M. Münter, 2019, International journal of radiation oncology, biology, physics.

Chemoradiation in female patients with anal cancer: Patient-reported outcome of acute and chronic side effects

J. Debus, K. Herfarth, F. Sterzing, 2018, Tumori.

EPEN-15. Radiotherapy with helium ions has the potential to improve both endocrine and neurocognitive outcome in pediatric patients with ependymoma

K. Herfarth, T. Tessonnier, J. Debus, 2022, Neuro-Oncology.

Chemoradiotherapy versus chemotherapy alone for unresected intrahepatic cholangiocarcinoma: practice patterns and outcomes from the national cancer data base.

C. Simone, Chi Lin, V. Verma, 2018, Journal of gastrointestinal oncology.

3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial

K. Herfarth, J. Debus, K. Zaoui, 2021, Radiation oncology.

TERT Promoter Mutations and Risk of Recurrence in Meningioma.

K. Aldape, Qianghu Wang, A. Becker, 2016, Journal of the National Cancer Institute.

Retrospective analysis of outcome and toxicity after postoperative radiotherapy in patients with squamous cell carcinoma of the lip

J. Debus, P. Plinkert, S. Akbaba, 2021, Tumori.

Melanotic Tumors of the Nervous System are Characterized by Distinct Mutational, Chromosomal and Epigenomic Profiles

Volker Hovestadt, Felix Sahm, David T. W. Jones, 2015, Brain pathology.

Metformin influences progression in diabetic glioblastoma patients

J. Debus, T. Bostel, A. Mohr, 2015, Strahlentherapie und Onkologie.

Analysis of a surgical series of 21 cerebral radiation necroses.

A. Unterberg, A. von Deimling, J. Debus, 2020, World neurosurgery.

Metformin Enhanced in Vitro Radiosensitivity Associates with G2/M Cell Cycle Arrest and Elevated Adenosine-5’-monophosphate-activated Protein Kinase Levels in Glioblastoma

J. Debus, A. Abdollahi, N. Nicolay, 2017, Radiology and oncology.

Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study

K. Herfarth, J. Debus, M. Kieser, 2021, BMC Cancer.

68Ga-FAPI-PET/CT improves diagnostic staging and radiotherapy planning of Adenoid Cystic Carcinomas - imaging analysis and histological validation.

H. Kauczor, P. Choyke, M. Röhrich, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone.

J. Debus, S. Combs, T. Welzel, 2014, International journal of radiation oncology, biology, physics.

A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?

Thomas Welzel, Stephanie E Combs, Juergen Debus, 2014, Radiation oncology.

Carbon Ion Re-Irradiation for Recurrent Head-and-Neck Cancer: A Single-Institutional Experience.

K. Herfarth, J. Debus, P. Plinkert, 2019, International journal of radiation oncology, biology, physics.

The role of organ‐ and function‐preserving radiotherapy in the treatment of adenoid cystic carcinoma of the larynx

J. Debus, K. Herfarth, P. Plinkert, 2019, Head & neck.

C. Simone, V. Verma, E. Ludmir, 2020, Practical radiation oncology.

Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution’s Clinical Experience

K. Herfarth, A. Unterberg, J. Debus, 2018, Cancers.

The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience

J. Debus, K. Herfarth, P. Choyke, 2020, The Journal of Nuclear Medicine.

The role of FAPI-PET/CT for patients with malignancies of the lower gastrointestinal tract – first clinical experience

J. Debus, K. Herfarth, U. Haberkorn, 2020 .

Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy

M. Knoll, A. Abdollahi, C. Schwager, 2022, Cancers.

The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience.

J. Debus, K. Herfarth, A. Mock, 2019, Oral oncology.

Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control

K. Herfarth, J. Debus, P. Plinkert, 2019, Cancers.

Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety

J. Debus, K. Herfarth, P. Plinkert, 2019, Cancer management and research.

Palliative Radiotherapy for Leptomeningeal Carcinomatosis–Analysis of Outcome, Prognostic Factors, and Symptom Response

J. Debus, D. Weber, P. Hoegen, 2019, Front. Oncol..

Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions

K. Herfarth, J. Debus, P. Plinkert, 2019, Radiation oncology.

Re-irradiation in locally recurrent lung cancer patients

J. Debus, T. Welzel, H. Hoffmann, 2019, Strahlentherapie und Onkologie.

Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience

J. Debus, K. Zaoui, P. Plinkert, 2019, Radiation oncology.

Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution

K. Herfarth, J. Debus, T. Muley, 2019, Radiation Oncology.

Radiotherapy plus concomitant temozolomide in primary gliosarcoma

J. Debus, A. Unterberg, A. Deimling, 2016, Journal of Neuro-Oncology.

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects

S. Combs, T. Welzel, J. Debus, 2014, Radiation Oncology.

Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review

U. Haberkorn, J. Debus, F. Giesel, 2020, Cancers.

Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers

S. A. Koerber, F. Giesel, P. K. Plinkert, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas.

H. Schlemmer, M. Röhrich, U. Haberkorn, 2020, European journal of radiology.

Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in Glioblastoma

M. Röhrich, U. Haberkorn, F. Giesel, 2020, Nuklearmedizin.

Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review

U. Haberkorn, J. Debus, F. Giesel, 2021, EJNMMI Research.

Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy

S. Heiland, U. Haberkorn, C. Debus, 2018, Scientific Reports.

High-resolution FLAIR MRI at 7 Tesla for treatment planning in glioblastoma patients.

Nicolas G. R. Behl, M. Ladd, H. Schlemmer, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT

M. Röhrich, U. Haberkorn, F. Giesel, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

FAP imaging in rare cancer entities—first clinical experience in a broad spectrum of malignancies

D. Jäger, J. Debus, H. Gampp, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist’s point of view

J. Debus, T. Bostel, S. Adeberg, 2015, Radiation oncology.

Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma

J. Debus, W. Wick, S. Combs, 2015, BMC Cancer.

Single-Isocenter Volumetric Modulated Arc Therapy vs. CyberKnife M6 for the Stereotactic Radiosurgery of Multiple Brain Metastases

J. Debus, D. Weber, R. E. El Shafie, 2020, Frontiers in Oncology.

Outcome and prognostic factors in single brain metastases from small-cell lung cancer

A. Warth, A. Unterberg, J. Debus, 2018, Strahlentherapie und Onkologie.

Tumor treating fields as novel combination partner in the multimodal treatment of head and neck cancer

J. Hess, P. Huber, J. Debus, 2023, Head & neck.

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations

J. Debus, P. Hoegen, F. Weykamp, 2022, Frontiers in Oncology.

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes

K. Herfarth, K. Schubert, J. Debus, 2023, Frontiers in Oncology.

Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Administration Rates

J. Debus, Michael Thomas, C. Heussel, 2020, Frontiers in Oncology.

Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC.

J. Debus, L. König, P. Christopoulos, 2023, Clinical lung cancer.

Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability

K. Herfarth, P. Plinkert, G. Dyckhoff, 2022, Radiation Oncology.

Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.

J. Debus, Michael Thomas, L. König, 2016, Lung cancer.

Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases—Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept

J. Debus, D. Weber, P. Hoegen, 2019, Cancers.

Treatment of meningioma and glioma with protons and carbon ions

J. Debus, N. Grau, V. Verma, 2017, Radiation Oncology.

Radiotherapy with Helium Ions Has the Potential to Improve Both Endocrine and Neurocognitive Outcome in Pediatric Patients with Ependymoma

K. Herfarth, T. Tessonnier, J. Debus, 2022, Cancers.

Neurocognitive Outcomes in Pediatric Patients Following Brain Irradiation

K. Herfarth, A. Unterberg, J. Debus, 2021, Cancers.

Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T

Daniel Paech, Peter Bachert, Jan-Eric Meissner, 2019, Journal of magnetic resonance imaging : JMRI.

Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients

Sebastian Bickelhaupt, Daniel Paech, Alexander Radbruch, 2018, Oncotarget.

Evaluation of Chemoradiotherapy with Carbon Ions and the Influence of p53 Mutational Status in the Colorectal Carcinoma Cell Line HCT 116

J. Debus, K. Weber, S. Combs, 2014, Tumori.

Assessment of Sodium MRI at 7 Tesla as Predictor of Therapy Response and Survival in Glioblastoma Patients

Nicolas G. R. Behl, M. Ladd, H. Schlemmer, 2021, Frontiers in Neuroscience.

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy

J. Debus, V. Verma, S. Adeberg, 2018, Cancer management and research.

Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: A multicenter DKTK/ROG analysis.

A. Boulesteix, V. Budach, J. Debus, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

FAP-Specific Signalling Is an Independent Diagnostic Approach in ACC and Not a Surrogate Marker of MRI Sequences

H. Schlemmer, M. Röhrich, U. Haberkorn, 2022, Cancers.

Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience

J. Debus, K. Zaoui, P. Plinkert, 2019, Radiation Oncology.

Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy

J. Debus, P. Plinkert, S. Akbaba, 2020, Cancer management and research.

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series

J. Debus, K. Herfarth, F. Sterzing, 2018, Cancer management and research.

Age-dependent hemato- and nephrotoxicity in patients with head and neck cancer receiving chemoradiotherapy with weekly cisplatin

J. Debus, K. Zaoui, K. Freier, 2019, Strahlentherapie und Onkologie.

The influence of hyperglycemia during radiotherapy on survival in patients with primary glioblastoma

J. Debus, T. Bostel, A. Mohr, 2016, Acta oncologica.

National Practice Patterns for Clinical T1N0 Nasopharyngeal Cancer in the Elderly: A National Cancer Data Base Analysis.

Chi Lin, W. Zhen, V. Verma, 2018, Anticancer research.

Generation of a New Disease‐specific Prognostic Score for Patients With Brain Metastases From Small‐cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS‐Score) and Validation of Two Other Indices

A. Warth, J. Debus, Michael Thomas, 2017, Clinical lung cancer.

Parenchymal and Functional Lung Changes after Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer—Experiences from a Single Institution

J. Debus, C. Heussel, L. König, 2017, Front. Oncol..

Tissue Retraction for Head and Neck Radiotherapy in Edentulous Patients.

P. Rammelsberg, F. S. Schwindling, S. Adeberg, 2021, The International journal of prosthodontics.

Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy.

A. Warth, J. Debus, F. Herth, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects

J. Debus, S. Combs, T. Welzel, 2014, Radiation oncology.

Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - how safe are protons?

K. Herfarth, M. Alber, T. Haberer, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Establishing stereotactic body radiotherapy with flattening filter free techniques in the treatment of pulmonary lesions - initial experiences from a single institution

B. Rhein, J. Debus, L. König, 2016, Radiation oncology.

Treatment of meningioma and glioma with protons and carbon ions

J. Debus, N. Grau, V. Verma, 2017, Radiation oncology.

Primary adenoid cystic carcinoma of the trachea: clinical outcome of 38 patients after interdisciplinary treatment in a single institution

K. Herfarth, J. Debus, T. Muley, 2019, Radiation oncology.

Oral Sequelae after Head and Neck Radiotherapy: RCT Comparing 3D-Printed Tissue Retraction Devices with Conventional Dental Splints

J. Debus, P. Rammelsberg, F. S. Schwindling, 2023, Journal of clinical medicine.

Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy

P. Hoegen, L. König, J. Hörner-Rieber, 2023, Radiation Oncology.

To Fly or not to Fly: Stereotactic MR-guided adaptive RadiotherapyEffectively Treats Ultracentral Lung Tumors with Favorable Long-Term Outcomes

J. Debus, P. Hoegen, F. Weykamp, 2023, Lung Cancer.

Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM)

J. Debus, S. Combs, T. Welzel, 2011, Radiation oncology.

Semi‐solid MT and APTw CEST‐MRI predict clinical outcome of patients with glioma early after radiotherapy

M. Ladd, A. Unterberg, P. Bachert, 2023, Magnetic resonance in medicine.

CEST Imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T.

M. Ladd, A. Unterberg, P. Bachert, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

EP-1215 Fibroblast Activating Protein specific PET for advanced target volume delineation in Glioblastoma

J. Debus, M. Röhrich, U. Haberkorn, 2019, Radiotherapy and Oncology.

Radiotherapy with Helium Ions Has the Potential to Improve Both Endocrine and Neurocognitive Outcome in Pediatric Patients with Ependymoma

K. Herfarth, T. Tessonnier, J. Debus, 2022, Cancers.

An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia.

J. Seuntjens, R. Tsang, R. Orecchia, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

OC-0514: radiation necrosis after proton beam therapy - when and where does it happen?

J. Debus, K. Herfarth, T. Haberer, 2017 .

Screening and Psycho-Oncological Support for Patients With Head and Neck Cancer and Brain Malignancies Before Radiotherapy With Mask Fixation: Results of a Feasibility Study

H. Friederich, K. Zaoui, C. Nikendei, 2021, Frontiers in Psychology.

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy

F. Weykamp, L. König, J. Hörner-Rieber, 2023, Clinical and translational radiation oncology.

IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT

M. Röhrich, T. Hielscher, A. von Deimling, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer

H. Kauczor, D. Jäger, M. Röhrich, 2019 .